Matthew Paul Del Giudice's most recent trade in Mira Pharmaceuticals Inc was a trade of 25,000 Stock Options (right to buy) done . Disclosure was reported to the exchange on Dec. 9, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mira Pharmaceuticals Inc | Matthew Paul Del Giudice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 25,000 | 75,000 | - | - | Stock Options (right to buy) | |
| Telomir Pharmaceuticals Inc | Matthew Paul Del Giudice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 25,000 | 25,000 | - | - | Incentive Stock Options (right to buy) |